About Nectar Laboratories Private Limited
Data last updated:
Nectar Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 March 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U65922TG1994PTC017176. Its GSTIN is 36AAACN7960P1ZS (Telangana).
The company has an authorised share capital of ₹9.5 Cr and a paid-up capital of ₹9.4 Cr. It was formerly known as Nectar Laboratories Ltd. It is led by directors including Veerraju Golla and Darla Prasad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Third Floor 6 – 2 – 1012 Tgv Mansion Rajbhavan Road Khairatabad, Hyderabad, Telangana, India – 500004.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.83 Cr, a decline of 76% compared to the previous year. For the same year it recorded a net loss of ₹28.89 Lakh (net margin -15.8%) and EBITDA of ₹28.61 Lakh (EBITDA margin 15.6%). Revenue has declined at a compounded annual rate (CAGR) of 55% over three years and 36% over five years.
As per MCA filings, the company has satisfied charges of ₹5.85 Cr on record. Court records list 26 cases involving the company, including 8 filed by the company and 15 filed against it; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nectarlabs.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressThird Floor 6 – 2 – 1012 Tgv Mansion Rajbhavan Road Khairatabad, Hyderabad, Telangana, India – 500004
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nectar Laboratories Private Limited
The main business activities of Nectar Laboratories are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nectar Laboratories Private Limited FY 2025 filings available
Nectar Laboratories Private Limited reported revenue of ₹1.83 Cr (down 76% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Nectar Laboratories Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 36% over five years, including a 76% fall in the latest year. EBITDA fell 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nectar Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹28.61 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹28.89 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nectar Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -15.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nectar Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Nectar Laboratories Private Limited
Nectar Laboratories Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Riya Exim Private Limited | ₹1.84 Cr (FY 2025) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Vishnu Poly-Chems Private Limited | ₹1.84 Cr (FY 2019) | •••• | •••• | -15.0% | •••• | Solapur, Maharashtra, India |
| Zochem Pharma Private Limited | ₹1.83 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Lucknow, Uttar Pradesh, India |
| Avery Pharmaceuticals Private Limited | ₹1.83 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Mumbai, Maharashtra, India |
| Suzikem Drugs Private Limited | ₹1.83 Cr (FY 2024) | •••• | •••• | -29.0% | •••• | Hyderabad, Telangana, India |
| Nectar Laboratories Private Limited this company | ₹1.83 Cr (FY 2025) | •••• | •••• | -76.0% | •••• | Hyderabad, Telangana, India |
| Imaec Limited | ₹1.83 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Nagpur, Maharashtra, India |
| Replica Remedies Private Limited | ₹1.81 Cr (FY 2019) | •••• | •••• | -60.0% | •••• | Ahmedabad, Gujarat, India |
| Sanctius Healthcare Private Limited | ₹1.81 Cr (FY 2019) | •••• | •••• | 13.0% | •••• | Silchar, Assam, India |
| Kendall Healthcare Private Limited | ₹1.81 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Hathras, Uttar Pradesh, India |
| Elfin Pharma Private Limited | ₹1.8 Cr (FY 2025) | •••• | •••• | 821.0% | •••• | Punjab, India |
Peers are the five companies nearest above and the five nearest below Nectar Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nectar Laboratories Private Limited
Nectar Laboratories Private Limited is audited by S.T.Mohite & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S.T.Mohite & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nectar Laboratories Private Limited
Nectar Laboratories has 4 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jyothsna Sunil Mysore Also directs: 3Pine Global Connect LLP, Adhezio LLP, Greenlands Flora International Limited and 3 more | Additional Director | 11 Dec 2024 | 1 Years 10 Months | Current |
| Veerraju Golla | Director | 19 Nov 2020 | 5 Years 10 Months | Current |
| Darla Prasad Also directs: Brilliant Therapeutics Private Limited | Director | 02 Jun 2021 | 5 Years 4 Months | Current |
| Sunoj Mysore Also directs: Adhezio LLP, Greenlands Flora International Limited, Adhezio Lifesciences Private Limited and 2 more | Director | 25 Apr 2022 | 4 Years 5 Months | Current |
Ownership and Shareholding of Nectar Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nectar Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Aug 1996 | Industrial Development Bank of India | ₹43 Lakh | Satisfied |
| 22 Jul 1996 | State Bank of Hyderabad | ₹77 Lakh | Satisfied |
| 25 Sep 1995 | State Bank of Hyderabad | ₹75 Lakh | Satisfied |
| 25 Sep 1995 | State Bank of Hyderabad | ₹75 Lakh | Satisfied |
| 25 Sep 1995 | State Bank of Hyderabad | ₹75 Lakh | Satisfied |
Total charge records: 6 View all charges
Legal Cases of Nectar Laboratories Private Limited
Nectar Laboratories Private Limited has 26 court cases on record: 8 filed by Nectar Laboratories, 15 filed against it, 3 where it is another party. 3 cases are pending and 23 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 17 | 7 | 1 |
| District courts | 7 | 7 | 0 |
| Supreme Court | 2 | 1 | 2 |
Cases on record (5 of 26)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (CAA) | Filed by the company against Pfizer Limited | Disposed |
| Bombay High Court | Court case (AO) | Filed by the company against Pfizer Limited | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (SUMMONS FOR JUDGT) | Filed against the company by Pfizer Limited | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CHAMBER SUMMONS) | Filed against the company by Wyeth Limited and 1 other | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by Wyeth Limited | Disposed |
Full case history
All 26 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Nectar Laboratories Private Limited
Nectar Laboratories Private Limited has 9 MSME Form 1 returns on record between 2019 and 2023, listing 68 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 14)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sri Maheshwari Printers | •••• | •••• | •••• |
| Arham Drugs and Chemicals Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Bhasin Packwell Pvt Ltd | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 9 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Nectar Laboratories Private Limited
Employment history and EPFO contributions of people linked to Nectar Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Nectar Laboratories Private Limited
Nectar Laboratories has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U65922TG1994PTC017176, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U65922TG1994PTC017176 | Current |
| U65922TG1994PLC017176 | Previous |
| U65922AP1994PLC017176 | Previous |
Recent Activity on Nectar Laboratories Private Limited
Nectar Laboratories Private Limited has 16 board changes on record since 2008: 4 appointments and 12 cessations. The latest: Jyothsna Sunil Mysore was appointed as Additional Director on 11 Dec 2024.
23 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Nectar Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nectar Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nectar Laboratories Private Limited
Nectar Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACN7960P1ZS | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nectar Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nectar Laboratories Private Limited
Nectar Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 March 1994 (32+ years old) and is registered under CIN U65922TG1994PTC017176.
Nectar Laboratories reported revenue of ₹1.83 Cr for FY 2025 (down 76% YoY).
Nectar Laboratories has 4 current directors:
- Jyothsna Sunil Mysore - Additional Director
- Veerraju Golla - Director
- Darla Prasad - Director
- Sunoj Mysore - Director
Nectar Laboratories reported a net loss of ₹28.89 Lakh (net margin -15.8%) and EBITDA of ₹28.61 Lakh (EBITDA margin 15.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nectar Laboratories is -55% over three years and -36% over five years. In the latest year (FY 2025) revenue fell 76%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nectar Laboratories is 36AAACN7960P1ZS, registered in Telangana.
The CIN (Corporate Identification Number) of Nectar Laboratories is U65922TG1994PTC017176. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nectar Laboratories has 26 court cases on record: 8 filed by the company and 15 filed against it. 3 are pending. Most are in the high courts.
Nectar Laboratories was incorporated on 10 March 1994, making it 32+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Nectar Laboratories by revenue are Riya Exim Private Limited, Vishnu Poly-Chems Private Limited, Zochem Pharma Private Limited, Avery Pharmaceuticals Private Limited, Suzikem Drugs Private Limited and 5 more, all in the Pharma industry (Formulations).
Jyothsna Sunil Mysore was appointed as Additional Director on 11 Dec 2024. Ramaswamy Natesaiyer ceased to be Director on 17 May 2022. Sunoj Mysore was appointed as Director on 25 Apr 2022. Nectar Laboratories has 16 board changes on record in total.
Nectar Laboratories has 9 MSME Form 1 returns on record between 2019 and 2023, listing 68 overdue payments to 14 micro and small suppliers. The latest return was filed on 23 Aug 2023.